l.sarkissian
TL2 Member · Bratislava, SK
Here for the documentation. Occasionally files a wiki request when a page has drifted out of date.
Joined 29 July 2025 · last posted 23d
88Posts here
4Topics
0Solutions
1.5kLikes received
1.2kLikes given
20Badges
231Days visited
4.8kPosts read
Most-liked posts
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #34 · Compounds › Other compounds · 11 Dec 2025 · 32 likes Anyone submitting an unusual compound for testing should tell the laboratory what it is rather than what it is sold as. Method selection depends on the structure and…
-
Comparing my trajectory with the trial curves, carefully Replied, post #16 · Outcomes › Progress reports · 21 Jun 2025 · 29 likes Picking up post #13: that is the part I would want checked first. Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #125 · Practice › Interactions · 13 Jun 2026 · 26 likes Insulin and sulfonylureas are the interaction that the labelling in this class flags most explicitly, because the risk is additive glucose lowering. That is a…
-
Constipation management, with a dietitian's contribution Replied, post #68 · Practice › Side effects · 21 May 2026 · 25 likes Post #64 and I disagree about the size of the effect, not about the direction. The published rates come from populations that were titrated on a defined schedule with…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #4 · Clinical › Comorbidities · 18 Mar 2025 · 24 likes A condition being an exclusion criterion in a trial does not mean the treatment is contraindicated. It frequently means the trialists wanted a cleaner population.
-
Follow-up: A partial dose because the pen emptied mid-injection Replied, post #8 · Practice › Administration · 23 Jul 2024 · 23 likes No notes. Posting so the count is not one.
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| Read the Guidelines | bronze | 30 Jul 2025 |
| Basic User | bronze | 31 Jul 2025 |
| First Topic | bronze | 3 Aug 2025 |
| First Reply | bronze | 5 Aug 2025 |
| First Link | bronze | 6 Aug 2025 |
| Welcome | bronze | 7 Aug 2025 |
| Member | bronze | 23 Aug 2025 |
| Generous | bronze | 29 Aug 2025 |
| Asked Well | bronze | 5 Sep 2025 |
| First Quote | bronze | 6 Sep 2025 |
| First Tag | bronze | 29 Sep 2025 |
| Sourced | bronze | 3 Nov 2025 |
| Reader | bronze | 7 Nov 2025 |
| Consistently Generous | silver | 11 Nov 2025 |
| Nice Topic | bronze | 4 Dec 2025 |
| Thank You | silver | 4 Dec 2025 |
| Nice Post | bronze | 7 Dec 2025 |
| Good Post | silver | 11 Dec 2025 |
| Editor | bronze | 24 Dec 2025 |
| Gives Back | gold | 8 Apr 2026 |